Other Indian states urged to follow Rajasthan on guidelines to doctors to prescribe generic drugs

19 May 2010

Efforts by the Indian Department of Pharmaceuticals (DoP) to promote unbranded generic drugs through Jan Aushadhi (peoples drug) Stores (which supply  cheaper medicines in India's state-run hospitals) received a boost this week with the state of Rajasthan government issuing guidelines to the doctors in the government hospitals to prescribe generic drugs. Some more states are expected to follow suit.

The Parliamentary Standing Committee on Health, meanwhile, suggested that it should be made mandatory for the state governments to open Jan Aushadhi outlets in all government hospitals to ensure this price benefit for a wider section of the public, reports the local news service PharmaBiz.

As well as expanding the network of Jan Aushadhi stores in different states, the DoP has been trying to persuade the Parliamentary Standing Committee, lauding the initiative suggested opening of generic outlets even in villages.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics